Risk factors for head and neck cancer in young adults: a pooled analysis in the INHANCE consortium

Imagem de Miniatura
Arquivos
art_TOPORCOV_Risk_factors_for_head_and_neck_cancer_in_2015.PDF (374.7 KB)
Citações na Scopus
132
Tipo de produção
article
Data de publicação
2015
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
OXFORD UNIV PRESS
Autores
TOPORCOV, Tatiana Natasha
ZNAOR, Ariana
ZHANG, Zuo-Feng
YU, Guo-Pei
WINN, Deborah M.
WEI, Qingyi
VILENSKY, Marta
VAUGHAN, Thomas
THOMSON, Peter
TALAMINI, Renato
Citação
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, v.44, n.1, p.169-185, 2015
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: Increasing incidence of head and neck cancer (HNC) in young adults has been reported. We aimed to compare the role of major risk factors and family history of cancer in HNC in young adults and older patients. Methods: We pooled data from 25 case-control studies and conducted separate analyses for adults <= 45 years old ('young adults', 2010 cases and 4042 controls) and > 45 years old ('older adults', 17 700 cases and 22 704 controls). Using logistic regression with studies treated as random effects, we estimated adjusted odds ratios (ORs) and 95% confidence intervals (CIs). Results: The young group of cases had a higher proportion of oral tongue cancer (16.0% in women; 11.0% in men) and unspecified oral cavity / oropharynx cancer (16.2%; 11.1%) and a lower proportion of larynx cancer (12.1%; 16.6%) than older adult cases. The proportions of never smokers or never drinkers among female cases were higher than among male cases in both age groups. Positive associations with HNC and duration or pack-years of smoking and drinking were similar across age groups. However, the attributable fractions (AFs) for smoking and drinking were lower in young when compared with older adults (AFs for smoking in young women, older women, young men and older men, respectively, =19.9% (95% CI = 9.8%, 27.9%), 48.9% (46.6%, 50.8%), 46.2% (38.5%, 52.5%), 64.3% (62.2%, 66.4%); AFs for drinking = 5.3% (-11.2%, 18.0%), 20.0% (14.5%, 25.0%), 21.5% (5.0%, 34.9%) and 50.4% (46.1%, 54.3%). A family history of early-onset cancer was associated with HNC risk in the young [OR = 2.27 (95% CI = 1.26, 4.10)], but not in the older adults [OR = 1.10 (0.91, 1.31)]. The attributable fraction for family history of early-onset cancer was 23.2% (8.60% to 31.4%) in young compared with 2.20% (-2 .41%, 5.80%) in older adults. Conclusions: Differences in HNC aetiology according to age group may exist. The lower AF of cigarette smoking and alcohol drinking in young adults may be due to the reduced length of exposure due to the lower age. Other characteristics, such as those that are inherited, may play a more important role in HNC in young adults compared with older adults.
Palavras-chave
Head and neck neoplasms, adult, smoking, alcohol drinking, diet
URI
https://observatorio.fm.usp.br/handle/OPI/9449
Referências
  1. Andisheh-Tadbir A, 2010, J CRANIOFAC SURG, V21, P126, DOI 10.1097/SCS.0b013e3181c46c10
  2. Annertz K, 2002, INT J CANCER, V101, P95, DOI 10.1002/ijc.10577
  3. Benhamou S, 2004, INT J CANCER, V112, P901, DOI 10.1002/ijc.20474
  4. BLOT WJ, 1988, CANCER RES, V48, P3282
  5. Boing AF, 2010, J EPIDEMIOL COMMUNIT, V65, P709
  6. Bosetti C, 2003, CANCER EPIDEM BIOMAR, V12, P1091
  7. Brenner DR, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-285
  8. BYERS RM, 1975, AM J SURG, V130, P475, DOI 10.1016/0002-9610(75)90487-0
  9. Chen KX, 2009, HEAD NECK-J SCI SPEC, V31, P175, DOI 10.1002/hed.20946
  10. Chen WY, 2011, JAMA-J AM MED ASSOC, V306, P1884, DOI 10.1001/jama.2011.1590
  11. Chuang SC, 2012, CANCER CAUSE CONTROL, V23, P69, DOI 10.1007/s10552-011-9857-x
  12. Conway DI, 2009, ORAL ONCOL, V45, P743, DOI 10.1016/j.oraloncology.2009.02.007
  13. Cui Y, 2006, INT J CANCER, V118, P714, DOI 10.1002/ijc.21413
  14. Dietz A, 2004, INT J CANCER, V108, P907, DOI 10.1002/ijc.11658
  15. Elahi A, 2002, CARCINOGENESIS, V23, P1229, DOI 10.1093/carcin/23.7.1229
  16. Falaki F, 2011, MED ORAL PATOL ORAL, V16, pE473, DOI 10.4317/medoral.16.e473
  17. Ferlay J, 2010, GLOBOCAN 2008 V1 2 C
  18. FRANCESCHI S, 1990, CANCER RES, V50, P6502
  19. Friedlander PL, 1998, HEAD NECK-J SCI SPEC, V20, P363, DOI 10.1002/(SICI)1097-0347(199808)20:5<363::AID-HED1>3.0.CO;2-W
  20. Funk GF, 2002, HEAD NECK-J SCI SPEC, V24, P165, DOI 10.1002/hed.10004
  21. Galli P, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-137
  22. Gawecki W, 2007, EUR ARCH OTO-RHINO-L, V264, P1459, DOI 10.1007/s00405-007-0386-x
  23. Gupta P C, 1999, J Indian Med Assoc, V97, P370
  24. Hart AKE, 1999, OTOLARYNG HEAD NECK, V120, P828, DOI 10.1016/S0194-5998(99)70322-0
  25. Hashibe M, 2006, CANCER EPIDEM BIOMAR, V15, P696, DOI 10.1158/1055-9965.EPl-05-0/10
  26. Hashibe M, 2007, J NATL CANCER I, V99, P777, DOI 10.1093/jnci/djk179
  27. Hayes RB, 1999, CANCER CAUSE CONTROL, V10, P27, DOI 10.1023/A:1008876115797
  28. Herrero R, 2003, J NATL CANCER I, V95, P1772, DOI 10.1093/jnci/djg/107
  29. Hirota SK, 2008, MED ORAL PATOL ORAL, V13, pE227
  30. Hyam DM, 2003, AUST DENT J, V48, P50, DOI 10.1111/j.1834-7819.2003.tb00009.x
  31. Iype EM, J POSTGRAD MED, V47, P171
  32. Kleinbaum D, 1982, EPIDEMIOLOGIC RES PR
  33. Kmietowicz Z, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3293
  34. KURIAKOSE M, 1992, ORAL ONCOL, V28B, P113
  35. Lagiou P, 2009, EUR J CANCER PREV, V18, P76, DOI 10.1097/CEJ.0b013e32830c8dca
  36. Levi F, 1998, INT J CANCER, V77, P705, DOI 10.1002/(SICI)1097-0215(19980831)77:5<705::AID-IJC8>3.0.CO;2-Z
  37. Lissowska J, 2010, CANCER CAUSE CONTROL, V21, P1091, DOI 10.1007/s10552-010-9537-2
  38. Llewellyn CD, 2004, ORAL ONCOL, V40, P304, DOI 10.1016/j.oraloncology.2003.08.015
  39. Llewellyn CD, 2003, ORAL ONCOL, V39, P106, DOI 10.1016/S1368-8375(02)00026-X
  40. Llewellyn CD, 2001, ORAL ONCOL, V37, P401, DOI 10.1016/S1368-8375(00)00135-4
  41. Llewellyn CD, 2004, J ORAL PATHOL MED, V33, P525, DOI 10.1111/j.1600-0714.2004.00222.x
  42. Luna-Ortiz Kuauhyama, 2011, Acta Otorrinolaringol Esp, V62, P113, DOI 10.1016/j.otorri.2010.09.016
  43. Macfarlane TV, 2010, CANCER CAUSE CONTROL, V21, P2213, DOI 10.1007/s10552-010-9641-3
  44. Mackenzie J, 2000, ORAL ONCOL, V36, P387, DOI 10.1016/S1368-8375(00)00009-9
  45. Mafi N, 2012, ASIAN PAC J CANCER P, V13, P3373, DOI 10.7314/APJCP.2012.13.7.3373
  46. Muscat JE, 1996, CANCER RES, V56, P5192
  47. NEGRI E, 1993, CANCER EPIDEM BIOMAR, V2, P189
  48. Negri E, 2009, INT J CANCER, V124, P394, DOI 10.1002/ijc.23848
  49. Olshan AF, 2000, CANCER EPIDEM BIOMAR, V9, P185
  50. Patel SC, 2011, J CLIN ONCOL, V29, P1488, DOI 10.1200/JCO.2010.31.7883
  51. Percy CL, 1990, INT CLASSIFICATION D
  52. Peters ES, 2005, CANCER EPIDEM BIOMAR, V14, P476, DOI 10.1158/1055-9965.EPI-04-0431
  53. Purdue MP, 2009, AM J EPIDEMIOL, V169, P132, DOI 10.1093/aje/kwn306
  54. Robinson KL, 2003, ORAL ONCOL, V39, P31, DOI 10.1016/S1368-8375(02)00014-3
  55. Rodriguez T, 2004, ORAL ONCOL, V40, P207, DOI 10.1016/S1368-8375(03)00168-4
  56. ROGERS MAM, 1993, CANCER EPIDEM BIOMAR, V2, P305
  57. Rosenblatt KA, 2004, CANCER RES, V64, P4049, DOI 10.1158/0008-5472.CAN-03-3425
  58. SANKARANARAYANAN R, 1989, BRIT J CANCER, V59, P439, DOI 10.1038/bjc.1989.89
  59. Santos-Silva AR, 2011, HISTOPATHOLOGY, V58, P1127, DOI 10.1111/j.1365-2559.2011.03863.x
  60. SCHANTZ SP, 1989, CANCER, V64, P1232, DOI 10.1002/1097-0142(19890915)64:6<1232::AID-CNCR2820640612>3.0.CO;2-U
  61. Schantz SP, 1997, LARYNGOSCOPE, V107, P765, DOI 10.1097/00005537-199706000-00011
  62. SCHANTZ SP, 1989, JAMA-J AM MED ASSOC, V262, P3313, DOI 10.1001/jama.262.23.3313
  63. SCHANTZ SP, 1988, CANCER, V62, P1374, DOI 10.1002/1097-0142(19881001)62:7<1374::AID-CNCR2820620723>3.0.CO;2-M
  64. Shiboski CH, 2005, CANCER-AM CANCER SOC, V103, P1843, DOI 10.1002/cncr.20998
  65. Siegelmann-Danieli N, 1998, J CLIN ONCOL, V16, P745
  66. Siriwardena BSMS, 2006, ORAL ONCOL, V42, P831, DOI 10.1016/j.oraloncology.2005.12.001
  67. Smith EM, 1998, LARYNGOSCOPE, V108, P1098, DOI 10.1097/00005537-199807000-00027
  68. Suzuki T, 2006, CANCER SCI, V97, P760, DOI 10.1111/j.1349-7006.2006.00232.x
  69. Szymanska K, 2011, CANCER CAUSE CONTROL, V22, P1037, DOI 10.1007/s10552-011-9779-7
  70. Thomas L, 2012, ANN OTO RHINOL LARYN, V121, P395
  71. Twardella D, 2006, J CLIN EPIDEMIOL, V59, P82, DOI 10.1016/j.jclinepi.2005.05.003
  72. United States Public Health Service Health Care Financing Administration Centers for Disease Control and Prevention (U.S.) Centers for Medicare & Medicaid Services (U.S.) National Center for Health Statistics (U.S.), 1995, ICD9CM HLTH CAR FIN
  73. Verschuur HP, 1999, LARYNGOSCOPE, V109, P249, DOI 10.1097/00005537-199902000-00015
  74. World Health Organization, 2005, INT STAT CLASS DIS R
  75. Zhang ZD, 2005, CANCER EPIDEM BIOMAR, V14, P1188, DOI 10.1158/1055-9965.EPI-04-0501

Coleções
Artigos e Materiais de Revistas Científicas - FM/MPR
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/28
Artigos e Materiais de Revistas Científicas - LIM/38
Artigos e Materiais de Revistas Científicas - ODS/03